Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination

Several COVID-19 vaccines are approved to prevent severe disease outcome after SARS-CoV-2 infection. Whereas induction and functionality of antiviral antibody response are largely studied, the induction of T cells upon vaccination with the different approved COVID-19 vaccines is less studied. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Maringer, Yacine, Nelde, Annika, Schroeder, Sarah M., Schuhmacher, Juliane, Hörber, Sebastian, Peter, Andreas, Karbach, Julia, Jäger, Elke, Walz, Juliane S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798886/
https://www.ncbi.nlm.nih.gov/pubmed/36318037
http://dx.doi.org/10.1126/sciimmunol.add3899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798886/
https://www.ncbi.nlm.nih.gov/pubmed/36318037
http://dx.doi.org/10.1126/sciimmunol.add3899

Ejemplares similares